Tracking down leaks in the blood-brain barrier

In epilepsy research, it has long been assumed that a leaky blood-brain barrier is a cause of inflammation in the brain. Using a novel method, researchers from the University of Bonn an the Bonn University Hospital (UKB) have demonstrated that the barrier between the blood and the central nervous system remains largely intact. The approach of their study provides important insights into the development of epilepsy and could significantly optimize drug development in the pharmaceutical industry. The study results have recently been published in the journal Nature Communications.

New compound inhibits influenza virus replication

Viruses use the molecular repertoire of the host cell to replicate. Researchers from the Cluster of Excellence ImmunoSensation2 at the University of Bonn, together with Japanese researchers, want to exploit this for the treatment of influenza. The team led by Prof. Hiroki Kato from the Institute of Cardiovascular Immunology at the University Hospital Bonn has identified a compound that inhibits the body's own methyltransferase MTr1, thereby limiting the replication of influenza viruses. The compound proved effective in lung tissue preparations and mouse studies and showed synergistic effects with already approved influenza drugs. The study is now published in the journal Science. 
 
 

Glial cells help memory along

There are two fundamentally different cell types in the brain, neurons and glial cells. The latter, for example, insulate the "wiring" of nerve cells or guarantee optimal working conditions for them. A new study led by the University of Bonn has now discovered another function in rodents: The results suggest that a certain type of glial cell plays an important role in spatial learning. The German Center for Neurodegenerative Diseases (DZNE) was involved in the work. The results have now been published in the journal Nature Communications.
 

A step towards precision oncology for patients with metastatic urothelial carcinoma

Dr. Niklas Klümper, resident at the Clinic for Urology and working group leader at the Institute for Experimental Oncology at the University Hospital Bonn (UKB), was awarded the C. E. Alken Prize in recognition of his outstanding scientific uro-oncological work. The 30 -year-old is investigating which patients with metastatic bladder cancer benefit from a new oncological form of therapy, the antibody-drug conjugates, in order to be able to use these promising drugs efficiently. His new findings were published this December in the renowned oncology journal Clinical Cancer Research.

Dean's office not occupied between Christmas and New Year

The Medical Dean's Office will not be staffed from 24 December 2022 to 1 January 2023. Accordingly, there will be no office hours and no telephone availability. From 02.01.2023, all work areas of the Dean's Office will be available again as usual. We wish you a peaceful time, a Merry Christmas and a Happy New Year.

Study by the Universities of Bonn and Heidelberg provides insights into a carefully choreographed dance

Nerve cells need a lot of energy and oxygen. They receive both through the blood. This is why nerve tissue is usually crisscrossed by a large number of blood vessels. But what prevents neurons and vascular cells from getting in each other's way as they grow? Researchers at the Universities of Heidelberg and Bonn, together with international partners, have identified a mechanism that takes care of this. The results have now appeared in the journal Neuron. 

New findings on memory impairment in epilepsy

People with chronic epilepsy often experience impaired memory. Researchers at the University of Bonn have now found a mechanism in mice that could explain these deficits. The German Center for Neurodegenerative Diseases (DZNE) was also involved in the study. The results are published in the journal Brain, but a preliminary version is already available online.

Cleft lip and palate: News from the genes

Cleft lip and palate are among the most common congenital malformations, which are mainly due to genetic causes. It is not yet known exactly which genes are affected. A study led by the University of Bonn has now uncovered new correlations: New mutations near known genes such as SPRY1 could contribute to the increase in disease risk. There is also evidence that the transcription factor Musculin is causally involved. The results have now been published online in advance in the journal Human Genetics and Genomics Advances. The final version will follow soon.

Wird geladen